Evidence map›Paper›PMID 41495708›Full record

ArticleBMC pulmonary medicine2026

Preclinical assessment of inhalational subacute safety of nebulized MP-171 (BromAc®).

Ahmed H Mekkawy, Md Khalilur Rahman, Krishna Pillai, Samina Badar, Mirela Simic, Javed Akhter, Sarah J Valle, David L Morris

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahmed H MekkawyMucpharm Pty Ltd., Sydney, NSW, 2217, Australia.
Md Khalilur RahmanMucpharm Pty Ltd., Sydney, NSW, 2217, Australia.
Krishna PillaiMucpharm Pty Ltd., Sydney, NSW, 2217, Australia.
Samina BadarDepartment of Surgery, St George Hospital, Sydney, NSW, 2217, Australia.
Mirela SimicMucpharm Pty Ltd., Sydney, NSW, 2217, Australia.
Javed AkhterMucpharm Pty Ltd., Sydney, NSW, 2217, Australia.
Sarah J ValleMucpharm Pty Ltd., Sydney, NSW, 2217, Australia.
David L MorrisMucpharm Pty Ltd., Sydney, NSW, 2217, Australia. david@mucpharm.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BromAc

Indexed as

LungAcetylcysteineAdministration, InhalationAnimalsBody WeightBromelainsCytokinesDose-Response Relationship, DrugDrug CombinationsDrug Evaluation, PreclinicalFemaleMaleMiceMice, Inbred BALB CNebulizers and VaporizersAcetylcysteinebromelain and acetylcysteine drug combinationBromelainsCytokinesDrug CombinationsBromAc®CytokinesExtended safetyPreclinicalRespiratory

Identifiers

PMID41495708
PMCPMC12870228

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.